Omnipod® 5 Academy
Register for the upcoming live Omnipod 5 Educational Webinars
Are you considering starting your type 1 diabetes patients on Omnipod 5 Automated Insulin Delivery System and want to learn more?
Our educational webinars highlight the clinical data that demonstrates improved time in range1 with Omnipod 5 system features and benefits for a variety of users, how to initiate and manage patients, along with common onboarding and optimisation topics.
Each webinar is delivered by international diabetes experts with practical clinical experience using the Omnipod 5 system.
You will also have the opportunity to ask questions to the panel.
Feel free to register and join multiple webinars.
Watch previous Webinars
Missed a session? Jump to each of the sections below and learn about the Omnipod 5 System
Learn about the unique features offered by Omnipod 5 that can benefit a variety of people living with type 1 diabetes.
Ready to get your patients started on Omnipod 5? Learn from other HCPs on how they educate, train and onboard their patients. With hands on experience, these HCPs share practical tips and tricks to set your patients up for success.
These webinars guide you on how to get the most out of Omnipod 5 for your patients. Each session may have a different patient subgroup or focus, to help you understand the unique considerations to initiation and management of your patients. Learn from real case study examples in order to put the tips into practice.
Awareness Webinars
March 2025
Understanding Omnipod® 5 and Strategies for Success
With Dr. Bernard Gehr, Dr. Inge Van Boxealer and Dr. Fiona Campbell
Connect & Learn from your peers. Join our latest webinar to hear all you want to know about Omnipod 5. Our engaging speaker panel Dr. Bernard Gehr and Dr. Inge Van Boxealer will share clinical data supporting the use of Omnipod 5 in broad populations, provide an overview of the algorithm and system functionality and review clinical case examples from their practices.
February 2025
Gain Clinical Efficiencies with Simple to use Automated Insulin Delivery Technology
With Prof. Pratik Choudhary, Dr. Winfried Keuthage, John Pemberton
Hear about the AID Consensus Guidance on training and education for AID technology, the latest data on virtual learning, and how to gain efficiencies in your clinic while using Omnipod 5.
December 2024
Practical Peer Discussion: young and older adults
- Omnipod 5 System and functionality overview
- Clinical guidelines to consider
- Practical implementation strategies for this patient group
Dr. Emma Wilmot, MB ChB, PhD
Endocrinologist, University Hospitals of Derby & Burton NHS, Honorary Associate (Clinical) Professor, University of Nottingham, United Kingdom
Dr. Stefan Golz
Diabetologist DDG, Specialist in Internal Medicine, amedes MVZ for Diabetology, Esslingen, Germany
October 2024
Optimising skin health with wearable diabetes technology
- Understand different skin reactions related to diabetes technology use and their risk factors
- Clinical data review of diabetes technology and skin reactions
- Prevention and management strategies
Prof. Michael Joubert
Adult endocrinologist and diabetologist, Caen-Normandy University, France
Dr. Maxwell Sauder
Dermatologist and assistant professor, University of Toronto, Canada
September 2024
Practical Peer Discussion: Paediatrics
- Omnipod 5 functionality overview
- Clinical guidelines to consider
- Omnipod 5: who/when/why/how to use in paediatrics
Francesca Annan BSc (Hons), MSc, RD, SP
Paediatric diabetes specialist dietitian, UCL Hospitals, UK
Dr. Ruben Willemsen
Paediatric endocrinologist, Barts Health NHS Trust, UK
April 2024
Understanding Omnipod® 5 with Compatible Sensor Options
- Review of recent RCT and RWE that highlights positive outcomes using Omnipod 5
- Omnipod 5 system functionality overview
- Specifics of the compatible sensors: Dexcom G6 and FreeStyle Libre 2 Plus
Dr. Anna-Kaisa Tuomaala
Paediatric Endocrinologist Helsinki University Central Hospital, Finland
Dr. Lalantha Leelarathna
Clinical Senior Lecturer, Imperial College Healthcare NHS Trust, UK
Optimisation Webinars
May 2025
Peer Experience Sharing: Omnipod 5 Initiation and Optimisation Strategies for Success
With Dr. Sufyan Hussain and Dr. Peter Adolfsson
Connect & Learn from your peers. Join our latest webinar to hear from our speakers on their clinical experience on how best to initiate and optimise patients with Omnipod 5.
December 2024
Optimisation strategies for young and older adults
- Omnipod 5 system and functionality overview
- Clinical guidelines to consider
- Setting up patients for success via discussion, education and practical implementation strategies
Dr Fraser Gibb
Consultant Physician and Honorary Clinical Reader, University of Edinburgh
October 2024
Optimisation strategies for paediatric patients
- Strategies for success using unique features of Omnipod 5
- General optimisation strategies for paediatric patients
- Introduction to the PANTHERTOOL
- Practical application via case studies
Cari Berget, MPH, RN, CDCES
Instructor, Pediatrics Barbara Davis Center Manager, Pediatric Artificial Pancreas Research University of Colorado Aurora, CO USA
Dr. Stephen Greene
Consultant diabetologist (paediatrics and adolescents), London Medical, UK
1. Forlenza G, et al. Diabetes Technol Ther. 2024. 26(8):514-525. Retrospective analysis of real-world data of 2,378 adults with type 1 diabetes using the Omnipod 5 System at the 6.1 mmol/L or 110 mg/dL Target Glucose utilized Omnipod DASH prior to starting on Omnipod 5. Time in range (3.9-10 mmol/L or 70-180 mg/dL) and time below range (<3.9 mmol/L or <70 mg/dL) improved after initiating the Omnipod 5 System, changing from a median 65.1% to 73.3% TIR, 2.02% to 1.06% time below range. 1,204 children and adolescents with type 1 diabetes using the Omnipod 5 System at the 6.1 mmol/L or 110 mg/dL Target Glucose setting utilized Omnipod DASH prior to starting on Omnipod 5. TIR (3.9-10 mmol/L or 70 mg/dL-180 mg/dL) and time below range (<3.9 mmol/L or <70 mg/dL) improved significantly after initiating the Omnipod 5 System, changing from a median 60.5% to 69.3% TIR, 2.12% to 1.54% time <3.9 mmol/L or <70mg/dL (p<0.05). Omnipod 5 results based on users with ≥90 days CGM data, ≥75% of days with ≥220 readings available.